SAMHD1 and primary cutaneous T-cell non-Hodgkin lymphoma: This agrees with previous reports of downregulated SAMHD1 expression in chronic lymphocytic leukemia, cutaneous T-cell lymphoma, and lung adenocarcinoma [10,11,13,18].